The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria
Manuel de Lera Ruiz(United States Military Academy), John A. McCauley(Fox Chase Cancer Center), Johnathan Robbins(United States Military Academy), Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Alan F. Cowman(Walter and Eliza Hall Institute of Medical Research), Marissa Vavrek(United States Military Academy), Kate E. Jarman(Walter and Eliza Hall Institute of Medical Research), Anna Ngo(Walter and Eliza Hall Institute of Medical Research), Justin A. Boddey(The University of Melbourne), Brad E. Sleebs(The University of Melbourne), Kym N. Lowes(The University of Melbourne), Paola Favuzza(The University of Melbourne), Dongmei Zhan(Marine Biology Institute of Shandong Province), Christopher W. Boyce(Scripps Research Institute), Bin Hu(South China University of Technology), Lianyun Zhao(United States Military Academy), Zhuyan Guo(United States Military Academy), David B. Olsen, Jennifer K. Thompson(Walter and Eliza Hall Institute of Medical Research), Zhiyu Lei
Cited by 26
Related Papers
Nuclear-encoded proteins target to the plastid in <i>Toxoplasma gondii</i> and <i>Plasmodium falciparum</i>
|Proceedings of the National Academy of Sciences|1998|703
Energy-Latency Tradeoff for Energy-Aware Offloading in Mobile Edge Computing Networks
|IEEE Internet of Things Journal|2017|577
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
|Science Translational Medicine|2015|541
Antibiotic Susceptibility Profiles of <i>Escherichia coli</i> Strains Lacking Multidrug Efflux Pump Genes
|Antimicrobial Agents and Chemotherapy|2001|502